CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
about
Role of Chemokines in Non-Small Cell Lung Cancer: Angiogenesis and InflammationA meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancerCXCR4 over-expression and survival in cancer: a system review and meta-analysisLoss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC.The intricate role of CXCR4 in cancer.Clinicopathological significance of CXCR4 in non-small cell lung cancer.Targeting chemokine receptor CXCR4 for treatment of HIV-1 infection, tumor progression, and metastasis.Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axisLow ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer.Chemokine receptor CXCR4 expression and lung cancer prognosis: a meta-analysisExpression of CXCR4 and non-small cell lung cancer prognosis: a meta-analysisHuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancyCXCR4/CXCL12 axis in non small cell lung cancer (NSCLC) pathologic roles and therapeutic potential.A method for biomarker directed survival prediction in advanced non-small-cell lung cancer patients treated with Carboplatin-based therapy.Imaging agents for the chemokine receptor 4 (CXCR4).Primary treatment for oropharyngeal squamous cell carcinoma in Alberta, Canada: A population-based study.Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell.Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung.Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET.Expression of the DNA repair gene MLH1 correlates with survival in patients who have resected pancreatic cancer and have received adjuvant chemoradiation: NRG Oncology RTOG Study 9704.Cav3.1 overexpression is associated with negative characteristics and prognosis in non-small cell lung cancer.Interaction of the chemokines I-TAC (CXCL11) and SDF-1 (CXCL12) in the regulation of tumor angiogenesis of colorectal cancer.SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.Correlation of High-Risk Soft Tissue Sarcoma Biomarker Expression Patterns with Outcome following Neoadjuvant Chemoradiation.CXCR4 Based Therapeutics for Non-Small Cell Lung Cancer (NSCLC)
P2860
Q26796395-A61DD31E-760B-4F68-9B84-3E90B9B43028Q26998677-574CC3CE-4416-4552-A8B7-82E93291973AQ28084663-222AEFE5-0C8A-4A48-88D0-54799024A425Q33888782-367F5019-B955-48E9-8173-75355634E2BCQ35067624-E91EB12F-5FCB-4454-B5C8-0DA528A72282Q35171366-46D620A6-C8FE-44E4-9B95-EDD277A07381Q35213463-2E5B0B2D-9A26-4506-A34D-9B302D3DE03FQ35550241-4E5E58F4-E505-4D27-8C73-48FA8D7A9894Q35578377-C71ACC6C-28BA-40D9-ABA5-1D19319709AAQ35676851-494B139C-920F-4C4D-9097-9CE9469637F2Q35791692-EAF4BE75-D997-49E6-A22E-F01B4D0EAB23Q35870804-FEF4CE93-4378-47BE-87D8-7CEEAC45F34DQ36373369-2D367A70-AF6C-4927-BE4C-53B33969106BQ36413831-FE7F8721-83A8-412A-8D0E-1DC77C036FF6Q36583985-5D7865D6-E9A0-4FB1-B0CD-4737603A29C8Q37384203-7A42AE52-2D42-4B6B-945C-A041A7FFE45FQ38022430-DA2CAD5E-404C-457E-86E6-47BCFB727D5EQ38637666-425294FA-1C72-485B-B79B-717ED012BA70Q38808628-0A765751-CC47-4A18-A6F8-A68045E11F18Q38961444-0D7F47B8-CE0C-42D8-905E-16CB838ABB3CQ39402696-37E75AAB-BB62-4893-BCA7-EBC7BB3BBCCEQ40051508-3C2966E9-E3CA-483F-BFD4-A2EA64B4070DQ47100529-DBE9E7B2-578E-4F2D-BC5D-BF7744478013Q47624692-ECAB109B-8D2D-4072-965D-55E27174041BQ50328652-BD59F87B-A335-47B7-8314-79CC4497829CQ50801488-5FD45247-C525-47D6-A320-168EDBED75E1Q52624081-C58A3056-399A-4DDF-84DA-58B50FB3B385Q53072244-87A3D8A5-432D-4758-BC5B-AB320971F0D0Q58696921-B2C93EC3-77CF-483B-AC49-5B49E4DC4143
P2860
CXCR4 overexpression is associated with poor outcome in females diagnosed with stage IV non-small cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@en
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@nl
type
label
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@en
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@nl
prefLabel
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@en
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@nl
P2093
P1476
CXCR4 overexpression is associ ...... IV non-small cell lung cancer.
@en
P2093
Alexander C Klimowicz
Anthony M Magliocco
D Gwyn Bebb
Desiree Hao
Don Morris
Erin Stolte
Huong Muzik
Karen Kopciuk
Shannon Otsuka
P304
P356
10.1097/JTO.0B013E3182199A99
P577
2011-07-01T00:00:00Z